Page last updated: 2024-11-07

prednisone and Vibrio cholerae Infection

prednisone has been researched along with Vibrio cholerae Infection in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amicizia, D1
Micale, RT1
Pennati, BM1
Zangrillo, F1
Iovine, M1
Lecini, E1
Marchini, F1
Lai, PL1
Panatto, D1
Jonker, EFF1
Uijlings, MAC1
Visser, LG1
Soonawala, D1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Study of Commercially Available Typhoid Point of Care Tests to Benchmark Current and Emerging Tools[NCT04673487]2,000 participants (Anticipated)Observational2021-01-31Not yet recruiting
Immune Response After Inactivated Oral Cholera Vaccine (Dukoral) in Renal Transplant Recipients[NCT01109914]Phase 451 participants (Actual)Interventional2010-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for prednisone and Vibrio cholerae Infection

ArticleYear
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.
    Journal of preventive medicine and hygiene, 2019, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Bicarbonates; C

2019

Trials

1 trial available for prednisone and Vibrio cholerae Infection

ArticleYear
Comparison of the immunogenicity of DukoralĀ® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.
    Vaccine, 2019, 05-21, Volume: 37, Issue:23

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Bacterial; Calcineurin Inhibitors; Cholera; Cholera Vacc

2019